There are numerous treatment options, including a variety of over-the-counter agents to help patients with constipation. Here, a review of the more popular choices.
When to start screening—and which patients to screen? And with which screening method? Recommendations here from a panel of experts.
Patients with ulcerative colitis and Crohn’s disease typically don’t receive preventive services at the same rate as general medical patients. Vaccination is a key area of confusion.
(AUDIO) There are disparities in the sensitivities and specificities of glucose and lactose hydrogen breath tests used to diagnose small intestine bacterial overgrowth and to distinguish patients with irritable bowel syndrome from healthy individuals. Just how useful are these tests? Insights from an expert here.
Several classes of drugs seem to have positive effects for patients with GI disorders--including NSAIDs, anticonvulsants, alpha-adrenergic agents, neuromuscular agents, and antidepressants. Details here.
Probiotics, prebiotics, herbal preparations, and acupuncture are among the most popular options pursued for GI disorders. But how helpful are these nonmedical options?
(AUDIO) Here, Christina Surawicz, MD, describes an organized approach to the evaluation and management of patients with chronic diarrhea.
Here: an update on the challenges of detection, diagnosis, and management of celiac disease and non–celiac disease and the importance of gluten sensitivity.
(AUDIO) According to the Centers for Disease Control, more than one-third of US adults are obese. The CDC also estimates that as many as 1.4 million Americans suffer from inflammatory bowel disorder. So is there a link?
Are you making the most out of your patients’ office visits? If you are not listening effectively, the answer is no, said Douglas A. Drossman, MD, at the American College of Gastroenterology 77th Annual Scientific Meeting in Las Vegas.